Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

4,816 Journal Article Views | Journal Analytics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper



Publication Date: 16 Mar 2010

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2010:2

doi: 10.4137/CMRT.S1600

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Libertas Academica
The publication of our paper in Bioinformatics and Biology Insights was highly professional and very pleasant on all levels: the guidelines for authors are concise, the online submission system is user-friendly, the comments from the reviewers were insightful and improved our paper, and the preparation of the manuscript for publication was efficient. I particularly liked the fast feedback from the staff on the state of the submission and review process.
Professor Werner Braun (Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas, USA)
More Testimonials

Quick Links


New article and journal news notification services